Literature DB >> 8386879

The two species of the foot-and-mouth disease virus leader protein, expressed individually, exhibit the same activities.

M Medina1, E Domingo, J K Brangwyn, G J Belsham.   

Abstract

Initiation of protein synthesis on the foot-and-mouth disease virus RNA occurs at two sites, thus, two forms of the leader protein, termed Lab and Lb, are produced. Plasmids have been constructed which encode these proteins either together or individually. Plasmids encoding the Lab protein alone express a modified form of this protein in which the second methionine residue, which corresponds to the first amino acid of Lb, is changed to an alternative residue. Four different mutant forms of the Lab sequence were made. Each of the plasmids was introduced into a mammalian cell transient expression system which allowed the determination of the known activities of the L proteins. It was shown that the Lb protein and each of the modified Lab proteins were capable of cleaving the L/P1 junction in trans. Furthermore, each of these proteins induced the cleavage of the p220 component of the cap-binding complex (eIF-4F) producing inhibition of cap-dependent translation. These results indicate that the two species of L have the same functions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386879     DOI: 10.1006/viro.1993.1267

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  69 in total

1.  Truncated initiation factor eIF4G lacking an eIF4E binding site can support capped mRNA translation.

Authors:  I K Ali; L McKendrick; S J Morley; R J Jackson
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

2.  Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase.

Authors:  J Chinsangaram; M Koster; M J Grubman
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Internal ribosomal entry site-mediated translation initiation in equine rhinitis A virus: similarities to and differences from that of foot-and-mouth disease virus.

Authors:  T M Hinton; F Li; B S Crabb
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Comparison of the capacity of different viral internal ribosome entry segments to direct translation initiation in poly(A)-dependent reticulocyte lysates.

Authors:  Sylvie Paulous; Cécile E Malnou; Yanne M Michel; Katherine M Kean; Andrew M Borman
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

5.  Foot-and-mouth disease virus 3C protease induces cleavage of translation initiation factors eIF4A and eIF4G within infected cells.

Authors:  G J Belsham; G M McInerney; N Ross-Smith
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response.

Authors:  Teresa de Los Santos; Sonia de Avila Botton; Rudi Weiblen; Marvin J Grubman
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

7.  Recognition of picornavirus internal ribosome entry sites within cells; influence of cellular and viral proteins.

Authors:  L O Roberts; R A Seamons; G J Belsham
Journal:  RNA       Date:  1998-05       Impact factor: 4.942

8.  Foot-and-mouth disease virus structural protein VP3 degrades Janus kinase 1 to inhibit IFN-γ signal transduction pathways.

Authors:  Dan Li; Jin Wei; Fan Yang; Hua-Nan Liu; Zi-Xiang Zhu; Wei-Jun Cao; Shu Li; Xiang-Tao Liu; Hai-Xue Zheng; Hong-Bing Shu
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

9.  Aichi virus leader protein is involved in viral RNA replication and encapsidation.

Authors:  Jun Sasaki; Shigeo Nagashima; Koki Taniguchi
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  A conserved domain in the leader proteinase of foot-and-mouth disease virus is required for proper subcellular localization and function.

Authors:  Teresa de los Santos; Fayna Diaz-San Segundo; James Zhu; Marla Koster; Camila C A Dias; Marvin J Grubman
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.